Advertisement
Advertisement

VIR

VIR logo

Vir Biotechnology, Inc. Common Stock

5.49
USD
+0.06
+1.05%
Apr 17, 15:59 UTC -4
Closed
exchange

After-Market

5.50

+0.01
+0.15%

Vir Biotechnology, Inc. Common Stock Profile

About

Vir Biotechnology Inc. is a clinical-stage immunology company. It is focused on combining immunologic insights to treat and prevent serious infectious diseases. The company's development pipeline consists of product candidates targeting the hepatitis B virus, influenza A, human immunodeficiency virus and tuberculosis. Vir Biotechnology Inc. is based in San Francisco, United States.

Info & Links

CEO

Marianne De Backer

Headquarters

1800 OWENS STREET, SUITE 900
SAN FRANCISCO, CA 94158, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.vir.bio

Auditor

Ernst & Young LLP

Share holders

156

Employees

408

Vir Biotechnology, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

754.29M

Enterprise Value

441.96M

Enterprise Value/EBITDA(ttm)

-0.78

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

17.17

Price to Book(mrq)

1.09

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

97.64%

Operating Margin(ttm)

-678.40%

Profit Margin(ttm)

-3610.21%

Return on Equity(ttm)

-36.71%

Return on Invested Capital(ttm)

-40.19%

Return on Assets(ttm)

-31.00%

Income Statement

Revenue(ttm)

74.20M

Revenue Per Share(ttm)

0.54

Gross Profit(ttm)

73.36M

EBITDA(ttm)3

-567.21M

Net Income Available to Common(ttm)

-521.96M

Diluted EPS(ttm)

-3.92

Share Statistics

Beta (5Y Monthly)

0.64

52-Week Change

-31.01%

S&P 500 52-Week Change

5.43%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

137.14M

Dividend Yield

0.00%

Float4

116.24M

% Held by Insiders

15.60%

% Held by Institutions

65.32%

Balance Sheet

Total Cash(mrq)

994.73M

Total Cash Per Share(mrq)

7.25

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

8.71%

Quick Ratio(mrq)

8.94%

Book Value Per Share(mrq)

8.40

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.28

Free Cash Flow(ytd)

-450.28M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement